Mahima Datla

"Mahima Datla is Managing Director of Biological E. Limited who directly oversees strategic operations within the organization and leads the public policy work. Ms. Datla has been working with BE for the past 18 years and has served in various capacities across a diverse range of functions, including Biotechnology & Projects; Operations and Strategic Business Development. Under Ms. Datla’s leadership, BE has demonstrated a solid growth given the successful WHO pre-qualification and launch of the Pentavalent and JE vaccines.

"Apart from Biological E, Ms. Datla has served on the steering committee of DCVMN (Developing Countries Vaccine Manufacturers Network) and is currently the President of the alliance. She is a member of FICCI and CII National Biotech committees in India. She has also been on the board of GAVI (Global alliance for vaccines and immunization) from 2011 to 2014. She is currently a GHIT (Global Health Innovative Technology) fund board member, which is a Japanese government innovation healthcare fund for improving global access to healthcare." She is a Gavi board member until 30 June 2023.

"Apart from Biological E, Ms Datla has served on the steering committee of DCVMN (Developing Countries Vaccine Manufacturers Network) and is currently the President of the network. She is a member of FICCI (Federation of Indian Chambers of Commerce and Industry) and CII (Confederation of Indian Industry) National Biotech committees in India. She is currently a board member of the Global Health Innovative Technology fund – a Japanese government innovation healthcare fund for improving global access to healthcare. She is a member of the Board of Directors of the Sadhikaratha Foundation. She is also a member of the Life Sciences Advisory Committee formed by the Government of Telangana, India. Ms Datla was previously on the Board of Gavi from 2011 to 2014." [1]

• Strategic Advisory Committee, Hilleman Laboratories